Menu Search
Equities

Bangkok Dusit Medical Services PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BDMS-F:SET

Bangkok Dusit Medical Services PCL

Actions
  • Price (THB)21.10
  • Today's Change-0.10 / -0.47%
  • Shares traded1.00k
  • 1 Year change-12.81%
  • Beta--
Data delayed at least 15 minutes, as of Mar 02 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Institutional shareholders

5.85%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Feb 2026413.74m2.60%
FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 2025169.62m1.07%
Invesco Asset Management Ltd.as of 31 Jan 2026102.32m0.64%
Geode Capital Management LLCas of 25 Feb 202646.60m0.29%
Allspring Global Investments LLCas of 30 Jan 202641.57m0.26%
Invesco Advisers, Inc.as of 26 Feb 202637.15m0.23%
FIL Investment Management (Singapore) Ltd.as of 31 Dec 202533.40m0.21%
Nordea Investment Management ABas of 31 Dec 202531.52m0.20%
Schroder Investment Management (Hong Kong) Ltd.as of 31 Dec 202528.12m0.18%
UBS Asset Management (UK) Ltd.as of 03 Feb 202625.35m0.16%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.